Loading organizations...
CLIVI is a technology company.
CLIVI operates a specialized digital clinic, providing comprehensive treatment for obesity and type 2 diabetes. Its platform integrates personalized nutritional plans, modern pharmacological therapies, and continuous monitoring via a mobile application. This tech-enabled approach facilitates body analysis, food tracking, and direct communication with dedicated endocrinologists and internists, ensuring tailored home-based care.
Established in 2021, CLIVI emerged from the insight that chronic metabolic conditions demand more accessible and integrated care than traditional systems. Its founders recognized digital tools could deliver expert medical supervision and personalized interventions, overcoming geographical barriers. This vision aimed to transform long-term treatment through a multidisciplinary, technology-driven approach.
CLIVI serves patients seeking effective obesity and type 2 diabetes management, guiding them toward improved health outcomes. The company’s vision is to become Mexico's leading digital clinic for these conditions, expanding its reach and integrated care. CLIVI aims to empower individuals toward sustained wellness through continuous support and data-driven treatment.
CLIVI has raised $10.0M across 1 funding round.
CLIVI has raised $10.0M in total across 1 funding round.
Clivi is Mexico's first digital diabetes clinic, providing a technology-driven platform for comprehensive type 2 diabetes management.[2][3][4][5] It serves patients in Latin America by connecting them with endocrinologists, nutritionists, and psychologists via accessible channels like WhatsApp, while supplying glucometers, test strips, blood testing kits, and medication.[2][3][4] The platform solves critical access gaps—one endocrinologist per nearly 10,000 patients in Mexico—using AI for personalized monitoring and treatment plans, achieving 94% diabetes control within six months for thousands of users.[2][3] With $2 million in annual recurring revenue and 2,000 new patients monthly as of mid-2023, Clivi raised $10 million in seed funding in 2023 and targets 1 million patients across Latin America in five years.[3][4]
Founded in 2021 by Ricardo Moguel (CEO), Kyle, and Bruno, Clivi emerged from personal tragedy: two family friends died from diabetes complications due to inadequate treatment.[4] Targeting Latin America's 40 million diabetes cases—Mexico ranking sixth globally—the team built a digital clinic to optimize scarce medical capacity via phone-based distribution.[2][3][4] Early traction was rapid: live since October 2021, it became Mexico's second-largest private diabetes clinic in under a year by leveraging WhatsApp for direct patient access and feedback-driven improvements.[3][4]
(Note: A separate gaming-focused "Clivi" in Madrid exists but lacks the diabetes firm's prominence or funding[1]; this profile centers the healthtech leader.)
Clivi rides the digital health boom, projected to hit $1.5 trillion globally, amid rising diabetes cases (over 422 million worldwide, majority in low/middle-income regions like Latin America).[3] Timing aligns with mobile penetration enabling WhatsApp-based care, disrupting fragmented systems where diabetes kills (e.g., top cause for Mexican women).[2][4] Market forces favor it: chronic disease overload, doctor shortages, and post-pandemic telehealth normalization position Clivi to dominate Mexico then LatAm, influencing ecosystems by setting standards for AI-human hybrid clinics and B2B expansions.[3][4]
Clivi is poised to claim No. 1 status in Mexico by automating more via AI, scaling to enterprises, and hitting 10x revenue growth.[3][4] Trends like AI diagnostics, remote monitoring, and LatAm's 1 billion-diabetes projection by 2030 will propel it toward its 1 million-patient goal.[2][3] Its influence may evolve into a chronic disease platform beyond diabetes, redefining accessible care and inspiring regional healthtech. This digital pioneer turns a massive health crisis into scalable opportunity, echoing Livongo's U.S. impact but tailored for emerging markets.[3]
CLIVI has raised $10.0M in total across 1 funding round.
CLIVI's investors include Dalus Capital, Foundation Capital, Lotux, Adalberto Flores Ochoa, Ariel Lambrecht, Ricardo Weder, Juan Esteban Moctezuma, CFA, Suresh Batchu, Tara Syed, Vicente Aristegui, 500 Startups, Cathay Innovation.
CLIVI has raised $10.0M across 1 funding round. Most recently, it raised $10.0M Seed in June 2023.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jun 1, 2023 | $10.0M Seed | Dalus Capital, Foundation Capital | Lotux, Adalberto Flores Ochoa, Ariel Lambrecht, Ricardo Weder, Juan Esteban Moctezuma, CFA, Suresh Batchu, Tara Syed, Vicente Aristegui, 500 Startups, Cathay Innovation, Conexo Ventures, FEMSA Ventures, Next Billion Ventures, Quiet Capital |